Categories: News205 words0.8 min read

GSP partners with Quibim

DATE

October 26, 2022

CATEGORIES
SHARE

GSP are excited to announce our new partnership with Quibim. Combining best in class algorithms with sound metrology! Together, we are committed to ensuring high quality MRI data for use in generalizable AI.

As a company leading the way in the implementation of quantitative MRI, Gold Standard Phantoms are excited to announce our new partnership with Quibim. One of the European leaders in the field of artificial intelligence (AI) and medical imaging, aiming to revolutionise drug development and patient care pathways.

The use of high quality data for AI algorithms is highly important to increase its power in these areas, therefore it is of paramount importance that good metrological practices are used to ensure traceability back to reference standards. Gold Standard Phantoms will work together with Quibim to facilitate the use of imaging biomarkers in the clinics. We look forward to the opportunities this collaboration will bring in the medical field by driving forward quantitative measurements in artificial intelligence.

Quibim develops quantitative biomarkers, companion diagnostics and other imaging tools for systems biology applications, from immuno-oncology to neurology. Quibim partners with pharma industry and large real-world data players.

It is also the reference imaging platform behind for the largest internal research consortiums and biobanks in cancer.

Related articles